Skip to main content
Jonathan Glass, MD, Neurology, Atlanta, GA

Jonathan D Glass MD

Neurology•Atlanta, GA

Neurophysiology

"Professor of neurology and pathology at Emory University School of Medicine, Director of the Emory ALS Center"

Join to view full profile

  • 1365 Clifton Rd NeAtlanta, GA 30322

  • Phone+1 404-778-3444

Dr. Glass is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Glass' full profileAlready have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Neuropathology, 1989 - 1991
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1986 - 1989
  • University of Maryland
    University of MarylandInternship, Internal Medicine, 1985 - 1986
  • University of Vermont College of Medicine
    University of Vermont College of MedicineClass of 1985

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1996 - 2027
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • MD State Medical License
    MD State Medical License 1989 - 1996
  • Neuropathology
    American Board of Pathology Neuropathology
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014
  • CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014
  • CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Why This ALS Drug Was a Miss, Though It Hit the Target
    Why This ALS Drug Was a Miss, Though It Hit the TargetSeptember 17th, 2025
  • Experimental Treatment Could Be ‘Game-Changing’ for Genetic ALS, Experts Say
    Experimental Treatment Could Be ‘Game-Changing’ for Genetic ALS, Experts SayMay 2nd, 2019
  • ALS Patients Losing Time and Hope as They Wait for Insurers to Cover a Pricey New Drug
    ALS Patients Losing Time and Hope as They Wait for Insurers to Cover a Pricey New DrugMay 21st, 2018

Grant Support

  • Neuropathology CoreNational Institute On Aging2010–2012
  • Proteomic Markers For ALSNational Institute Of Neurological Disorders And Stroke2007–2008
  • Discovering Calpain Inhibitors For Neurological DiseasesNational Institute On Drug Abuse2007
  • Axonal Protection For Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2006–2007
  • UV Light And The Cutaneous Neurosensory SystemNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Jonathan Glass, Dr. Jonathan Glass, MD, Dr. J Glass, Dr. Jonathan D Glass